Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303 - Bartlett, N L; Wilson, W H; Jung, S H (J Clin Oncol, 2019)
et al.